Description du projet
Centre d’excellence européen pour le calcul haute performance dans la recherche en sciences de la vie
BioExcel est le principal centre d’excellence européen pour la recherche biomoléculaire computationnelle et un pôle d’innovation majeur pour le calcul scientifique. Les feuilles de route pour le développement de logiciels intègrent les commentaires recueillis auprès de milliers d’utilisateurs dans le monde entier et garantissent que les fonctionnalités les plus recherchées sont prioritaires. Des programmes de formation complets et un engagement avec l’industrie contribuent à combler le manque de compétences des chercheurs en sciences de la vie et soutiennent les efforts déployés à l’échelle mondiale pour relever des défis mondiaux tels que la préparation aux pandémies. Depuis 2015, BioExcel a construit un vaste réseau de partenaires composé d’organisations connexes, de fournisseurs de ressources, de vendeurs de matériel, d’équipes de développeurs de logiciels, de communautés d’utilisateurs et de l’industrie. Le projet BioExcel-3, financé par l’UE, entend capitaliser sur les succès engrangés par le centre jusqu’à présent et développer plus en profondeur la communauté du calcul haute performance durable en Europe.
Objectif
Life Science is turning into a data-driven and HPC dependent research field. BioTeam/Hyperion’s 2022 estimates show that 95% of Life Science projects are being dependent on HPC. The rapid response to Covid-19 showed how an EU collaboration between pharma industry, Life Science researchers and supercomputing centres resulted in several newly identified hits now undergoing clinical trials. Life Science is already delivering actual drug candidates within a year by using HPC in general, and BioExcel codes in particular (1000s of papers citing GROMACS or HADDOCK for SARS-CoV-2 simulations).
The Centre of Excellence for Computational Biomolecular Research (BioExcel) was established in 2015, and funded again in 2018, to help accelerate this development. The BioExcel-3 strategy to achieve significant impact relies on (i) ensuring that the most widely used European codes provide high performance, efficiency, scaling, reliability and quality to meet academic and industrial needs; (ii) identifying user needs to prioritise development of features with high scientific impact & performance/porting requests for deployment on EuroHPC resources; (iii) providing state-of-the-art training program for next-generation EU workforce on exploitation of ensemble algorithms, AI approaches, and convergence of HPC, HTC and HPDA; (iv) being the preferred EU partner for international organisations; (v) providing sustainable business paths for companies that need commercial support or want to fund development of specific features; and (vi) operating under an open governance model that provides transparency for the community and EC to be confident BioExcel makes the right priorities based on user and HPC needs.
BioExcel-3 will grow and sustain the Life Science HPC community in Europe. Our success will be measured by our ability to support codes and train scientists who produce almost 10,000 scientific papers and numerous industrial projects every year.
Champ scientifique
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- social sciencessociologygovernance
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- social scienceseconomics and businessbusiness and managementemployment
- social scienceseconomics and businesseconomicssustainable economy
Mots‑clés
Programme(s)
- HORIZON.2.4 - Digital, Industry and Space Main Programme
Régime de financement
HORIZON-JU-RIA - HORIZON JU Research and Innovation ActionsCoordinateur
100 44 Stockholm
Suède